☰

Marc M. Oshiro, Ph.D. - Publications

Affiliations: 
2000 University of Arizona, Tucson, AZ 
Area:
Pharmacology, Cell Biology, Toxicology
Tree Info Grants Similar researchers PubMed Report error

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Bixby B, Vrba L, Lenka J, Oshiro M, Watts GS, Hughes T, Erickson H, Chopra M, Knepler JL, Knox KS, Jarnagin L, Alalawi R, Kala M, Bernert R, Routh J, et al. Cell-Free DNA Methylation Analysis as a Marker of Malignancy in Pleural Fluid. Research Square. PMID 37886511 DOI: 10.21203/rs.3.rs-3390107/v1  0.581
2022 Vrba L, Futscher BW, Oshiro M, Watts GS, Menashi E, Hu C, Hammad H, Pennington DR, Golconda U, Gavini H, Roe DJ, Shroff RT, Nelson MA. Liquid biopsy, using a novel DNA methylation signature, distinguishes pancreatic adenocarcinoma from benign pancreatic disease. Clinical Epigenetics. 14: 28. PMID 35193708 DOI: 10.1186/s13148-022-01246-2  0.626
2020 Munugala N, Hammad H, Vrba L, Oshiro M, Wertheim B, Roe D, Gavini H, Latura L, Pennington D, Dalgai S, Babiker HM, Elquza E, Scott AJ, Nelson M, Futscher BW, et al. Detection of pancreatic cancer using a novel blood-based DNA methylation signature. Journal of Clinical Oncology. 38: e15546-e15546. DOI: 10.1200/Jco.2020.38.15_Suppl.E15546  0.647
2019 Vrba L, Oshiro MM, Kim SS, Garland LL, Placencia C, Mahadevan D, Nelson MA, Futscher BW. DNA methylation biomarkers discovered detect cancer in liquid biopsies from non-small cell lung cancer patients. Epigenetics. 1-12. PMID 31775567 DOI: 10.1080/15592294.2019.1695333  0.673
2008 Novak P, Jensen T, Oshiro MM, Watts GS, Kim CJ, Futscher BW. Agglomerative epigenetic aberrations are a common event in human breast cancer. Cancer Research. 68: 8616-25. PMID 18922938 DOI: 10.1158/0008-5472.Can-08-1419  0.734
2008 Junk DJ, Vrba L, Watts GS, Oshiro MM, Martinez JD, Futscher BW. Different mutant/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells. Neoplasia (New York, N.Y.). 10: 450-61. PMID 18472962 DOI: 10.1593/Neo.08120  0.781
2006 Novak P, Jensen T, Oshiro MM, Wozniak RJ, Nouzova M, Watts GS, Klimecki WT, Kim C, Futscher BW. Epigenetic inactivation of the HOXA gene cluster in breast cancer. Cancer Research. 66: 10664-70. PMID 17090521 DOI: 10.1158/0008-5472.Can-06-2761  0.794
2006 Li H, Watts GS, Oshiro MM, Futscher BW, Domann FE. AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells. Oncogene. 25: 5405-15. PMID 16636674 DOI: 10.1038/Sj.Onc.1209534  0.681
2005 Oshiro MM, Futscher BW, Lisberg A, Wozniak RJ, Klimecki WT, Domann FE, Cress AE. Epigenetic regulation of the cell type-specific gene 14-3-3sigma. Neoplasia (New York, N.Y.). 7: 799-808. PMID 16229802 DOI: 10.1593/Neo.05274  0.805
2005 Oshiro MM, Kim CJ, Wozniak RJ, Junk DJ, Muñoz-Rodríguez JL, Burr JA, Fitzgerald M, Pawar SC, Cress AE, Domann FE, Futscher BW. Epigenetic silencing of DSC3 is a common event in human breast cancer. Breast Cancer Research : Bcr. 7: R669-80. PMID 16168112 DOI: 10.1186/Bcr1273  0.732
2004 Nouzova M, Holtan N, Oshiro MM, Isett RB, Munoz-Rodriguez JL, List AF, Narro ML, Miller SJ, Merchant NC, Futscher BW. Epigenomic changes during leukemia cell differentiation: analysis of histone acetylation and cytosine methylation using CpG island microarrays. The Journal of Pharmacology and Experimental Therapeutics. 311: 968-81. PMID 15302897 DOI: 10.1124/Jpet.104.072488  0.738
2004 Watts GS, Oshiro MM, Junk DJ, Wozniak RJ, Watterson S, Domann FE, Futscher BW. The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells. Neoplasia (New York, N.Y.). 6: 187-94. PMID 15153330 DOI: 10.1593/Neo.3292  0.722
2003 Fitzgerald M, Oshiro M, Holtan N, Krager K, Cullen JJ, Futscher BW, Domann FE. Human pancreatic carcinoma cells activate maspin expression through loss of epigenetic control. Neoplasia (New York, N.Y.). 5: 427-36. PMID 14670180 DOI: 10.1016/S1476-5586(03)80045-3  0.7
2003 Oshiro MM, Watts GS, Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, Domann FE, Futscher BW. Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression. Oncogene. 22: 3624-34. PMID 12789271 DOI: 10.1038/Sj.Onc.1206545  0.76
2002 Futscher BW, Oshiro MM, Wozniak RJ, Holtan N, Hanigan CL, Duan H, Domann FE. Role for DNA methylation in the control of cell type specific maspin expression. Nature Genetics. 31: 175-9. PMID 12021783 DOI: 10.1038/Ng886  0.794
Show low-probability matches.